z-logo
open-access-imgOpen Access
Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket
Author(s) -
Lauren Wallon,
Imran Khan,
Kai Wen Teng,
Akiko Koide,
Mariyam Zuberi,
Jianping Li,
Gayatri Ketavarapu,
Nathaniel J. Traaseth,
John P. O’Bryan,
Shohei Koide
Publication year - 2022
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2204481119
Subject(s) - kras , druggability , small molecule , carcinogenesis , in vivo , cancer research , biology , mutant , gene isoform , chemistry , mutation , microbiology and biotechnology , biochemistry , cancer , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom